Showing results (371-380 of 465) with videos related to
Sort By:
Pageof 47
European Urology|September 18, 2012
ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladderMaximilian Burger, Willem Oosterlinck, Badrinath Konety, et al.Urologie (Heidelberg, Germany)|April 7, 2025
[Making prostate cancer research accessible: chatGPT-4 as a tool to enhance lay communication]Maximilian Haas, Veronika Saberi, Christopher Gossler, et al.Journal of Medical Internet Research|November 19, 2025
Using ChatGPT-4 for Lay Summarization in Prostate Cancer Research to Advance Patient-Centered Communication: Large-Scale Generative AI Performance EvaluationEmily Rinderknecht, Simon U Engelmann, Veronika Saberi, et al.World Journal of Urology|April 19, 2011
Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomyThomas F Chromecki, Behfar Ehdaie, Giacomo Novara, et al.European Urology Focus|November 25, 2018
Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines PanelViktor Soukup, Otakar Čapoun, Daniel Cohen, et al.Urologic Oncology|February 21, 2026
Progression-free survival with darolutamide and docetaxel vs. androgen receptor pathway inhibitors vs. docetaxel in metastatic hormone-sensitive prostate cancer: A real-world multicenter retrospective studyEmily Rinderknecht, Gloria Bielstein, Richard Cathomas, et al.Oncotarget|March 31, 2018
A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomyMarkus Eckstein, Ralph M Wirtz, Carolin Pfannstil, et al.Surgical Oncology|September 6, 2020
The association of cigarette smoking and pathological response to neoadjuvant platinum-based chemotherapy in patients undergoing treatment for urinary bladder cancer - A prospective European multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working groupPhilipp Gild, Malte W Vetterlein, Roland Seiler, et al.Urologic Oncology|February 25, 2024
Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancerNatalya Benderska-Söder, Thorsten Ecke, Lisa Kleinlein, et al.BJU International|January 14, 2010
Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trialChristian Bolenz, Edwin Herrmann, Patrick J Bastian, et al.Pageof 47